Cassava taps Freda Nassif as chief commercial officer as simufilam Phase 3 readout nears
Cassava Sciences (NASDAQ:SAVA) has tapped Freda Nassif as chief commercial officer, effective Nov. 18, 2024. Ms. Nassif is an ...
Cassava Sciences Appoints Freda Nassif as Chief Commercial Officer
Ms. Nassif brings an extensive track record of successfully developing commercial strategies for multiple FDA-approved drugsAppointment initiates ...
Business Insider16h
Cassava Sciences put volume heavy and directionally bearish
Bearish flow noted in Cassava Sciences (SAVA) with 3,180 puts trading, or 1.8x expected. Most active are 11/22 weekly 13 puts and 11/22 weekly 25 puts, with total volume in those strikes near 1,000 ...